Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock Medical Device Investing
Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress Medical Device Investing
OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results Medical Device Investing
Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation Biotech Investing